NCT04529967 Child-Parent Familial Hypercholesterolemia Screening
| NCT ID | NCT04529967 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's Hospital of Fudan University |
| Condition | Familial Hypercholesterolemia |
| Study Type | OBSERVATIONAL |
| Enrollment | 15,000 participants |
| Start Date | 2025-04-01 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 15,000 participants in total. It began in 2025-04-01 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Child-parent screening for familial hypercholesterolemia has been proposed to identify children and their parent who are carrier of mutations and with high risk for inherited premature coronary artery disease. The investigators assessed the efficacy and feasibility of such screening in primary care practice. key scientific questions: 1. The 95th and 99th percentile of finger blood TC in children of 2 years old. 2. Mutations that contribute to high TC status ( serum TC \>99th percentiles) compared with international FH48 panel for FH genetic screening.
Eligibility Criteria
Inclusion Criteria: * Receive routine child care * aged 1 - 3 years old ( date of investigate minus date of birth) Exclusion Criteria: * It is up to the researcher to decide whether it is suitable to participate in this research
Contact & Investigator
LIling Qian, Master
STUDY DIRECTOR
Children's Hospital of Fudan University
Frequently Asked Questions
Who can join the NCT04529967 clinical trial?
This trial is open to participants of all sexes, aged 1 Year or older, up to 3 Years, studying Familial Hypercholesterolemia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04529967 currently recruiting?
Yes, NCT04529967 is actively recruiting participants. Contact the research team at yanwl@fudan.edu.cn for enrollment information.
Where is the NCT04529967 trial being conducted?
This trial is being conducted at Hefei, China, Qidong, China, Shanghai, China, Taiyuan, China and 2 additional locations.
Who is sponsoring the NCT04529967 clinical trial?
NCT04529967 is sponsored by Children's Hospital of Fudan University. The principal investigator is LIling Qian, Master at Children's Hospital of Fudan University. The trial plans to enroll 15,000 participants.